Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 12876 - 12900 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:8398 osteoarthritis RGD:735196 Rattus norvegicus (Norway rat) 304135 Adamts5 mutant phenotype evidence used in manual assertion
  • PMID:23546441
DOID:6432 pulmonary hypertension RGD:3811 Rattus norvegicus (Norway rat) 24807 Tacr1 mutant phenotype evidence used in manual assertion
  • PMID:12662901
DOID:4450 renal cell carcinoma HGNC:11904 Homo sapiens (human) 8797 TNFRSF10A mutant phenotype evidence used in manual assertion
  • PMID:17184908
DOID:2797 idiopathic interstitial pneumonia HGNC:3942 Homo sapiens (human) 2475 MTOR mutant phenotype evidence used in manual assertion
  • PMID:21444868
DOID:3717 gastric adenocarcinoma HGNC:12825 Homo sapiens (human) 7514 XPO1 mutant phenotype evidence used in manual assertion
  • PMID:30115935
DOID:11206 opioid abuse RGD:67378 Rattus norvegicus (Norway rat) 24586 Ncam1 mutant phenotype evidence used in manual assertion
  • PMID:24399412
DOID:9744 type 1 diabetes mellitus RGD:2866 Rattus norvegicus (Norway rat) 25712 Ifng mutant phenotype evidence used in manual assertion
  • PMID:8977415
DOID:9352 type 2 diabetes mellitus HGNC:9236 Homo sapiens (human) 5468 PPARG mutant phenotype evidence used in manual assertion
  • PMID:18394743
DOID:3021 acute kidney failure HGNC:453 Homo sapiens (human) 259 AMBP mutant phenotype evidence used in manual assertion
  • PMID:8963945
DOID:0050659 biotin-responsive basal ganglia disease WB:WBGene00044738 Caenorhabditis elegans 4363081 folt-3 mutant phenotype evidence used in manual assertion
  • PMID:17475669
DOID:9744 type 1 diabetes mellitus HGNC:11290 Homo sapiens (human) 6721 SREBF2 mutant phenotype evidence used in manual assertion
  • PMID:18682608
DOID:11049 meconium aspiration syndrome RGD:2072 Rattus norvegicus (Norway rat) 24182 Agtr2 mutant phenotype evidence used in manual assertion
  • PMID:14605247
DOID:0050873 follicular lymphoma HGNC:1699 Homo sapiens (human) 974 CD79B mutant phenotype evidence used in manual assertion
  • PMID:17374736
DOID:9256 colorectal cancer HGNC:76 Homo sapiens (human) 25 ABL1 mutant phenotype evidence used in manual assertion
  • PMID:32850446
DOID:9352 type 2 diabetes mellitus HGNC:2159 Homo sapiens (human) 1268 CNR1 mutant phenotype evidence used in manual assertion
  • PMID:18678611
DOID:3910 lung adenocarcinoma HGNC:27230 Homo sapiens (human) 157570 ESCO2 mutant phenotype evidence used in manual assertion
  • PMID:33573689
DOID:0060161 Kennedy's disease HGNC:644 Homo sapiens (human) 367 AR mutant phenotype evidence used in manual assertion
  • PMID:26942099
DOID:9119 acute myeloid leukemia HGNC:7132 Homo sapiens (human) 4297 KMT2A mutant phenotype evidence used in manual assertion
  • PMID:33542482
DOID:1612 breast cancer HGNC:206 Homo sapiens (human) 10863 ADAM28 mutant phenotype evidence used in manual assertion
  • PMID:19549921
DOID:0050855 renal fibrosis RGD:3907 Rattus norvegicus (Norway rat) 24854 Clu mutant phenotype evidence used in manual assertion
  • PMID:22052058
DOID:234 colon adenocarcinoma HGNC:21686 Homo sapiens (human) 8635 RNASET2 mutant phenotype evidence used in manual assertion
  • PMID:30842415
DOID:3910 lung adenocarcinoma HGNC:18505 Homo sapiens (human) 54894 RNF43 mutant phenotype evidence used in manual assertion
  • PMID:31286874
DOID:10908 hydrocephalus RGD:2927 Rattus norvegicus (Norway rat) 24511 Itgb1 mutant phenotype evidence used in manual assertion
  • PMID:19726708
DOID:0081082 acute myelomonocytic leukemia HGNC:3765 Homo sapiens (human) 2322 FLT3 mutant phenotype evidence used in manual assertion
  • PMID:22187040
DOID:2394 ovarian cancer HGNC:1689 Homo sapiens (human) 966 CD59 mutant phenotype evidence used in manual assertion
  • PMID:19254481
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025